Ausgabe 2/2022
Inhalt (20 Artikel)
Renal cell carcinoma—presentation highlights from the ESMO Congress 2021
- short review
Georg C. Hutterer, Martin Pichler
Agony of choice—selecting chronic lymphocytic leukemia treatment in 2022
- Open Access
- short review
Jan-Paul Bohn
Current state of clinical development of TROP2-directed antibody–drug conjugates for triple-negative breast cancer
- Open Access
- short review
Maximilian Marhold
Tracking mutation and drug-driven alterations of oncokinase conformations
- Open Access
- short review
Andreas Feichtner, Valentina Kugler, Selina Schwaighofer, Thomas Nuener, Jakob Fleischmann, Eduard Stefan
Systemic capillary leak syndrome following granulocyte colony-stimulating factor therapy in a T-lymphoblastic leukemia/lymphoma patient: a case report
- case report
Ahmed H. Al Sharie, Yazan O. Al Zu’bi, Sarah Al Sharie, Hawra A. Baydoun, Farah H. Atawneh, Osama Alshari, Dima Albals
Hemophagocytic lymphohistocytosis in a COVID-19 patient in the acute phase: case report
- case report
Maher Salamoon, Mazen Kenj
High mortality in patients with active malignancy and severe COVID-19
- original report
Simon Udovica, Nino Müser, Agnes Pechlaner, Andreas Reichinger, Christoph Aichinger, Kathrin Strasser-Weippl, Holger Rumpold, Andreas Petzer, Ewald Wöll, Wolfgang Hilbe, Ercan Müldür
Cardiopulmonary sequelae of COVID-19
- interview
Neurotoxicity as a rare side effect of immune checkpoint inhibitors. A case report and review of the literature
- case report
Simon Udovica, Kathrin Strasser-Weippl, Eva Fischer, Dora Niedersüß-Beke
Immunotherapy pitfall: sarcoid-like reaction mimicking disease progression in advanced melanoma treated with nivolumab
- case report
Beatrix Mutschlechner, Susanne Dertinger, Felix Offner, Veronika Buck, Alexander Becherer, Klaus Gasser, Bernd Hartmann, Thomas Winder
